Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Clinical trial NCT02446795 · UNKNOWN
Trial details
- NCT number
- NCT02446795
- Sponsor
- Consorzio Oncotech
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.